/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S.
WIRE SERVICES/
WINNIPEG and SMITH FALLS, ON, Nov.
8, 2017 /CNW/ - Canopy Growth Corporation (TSX:WEED)
(Canopy Growth) and Delta 9 Cannabis Inc. (TSX.V:NINE) ("Delta 9"
or together, the "Companies") applaud the framework today announced
by the Province of Manitoba
regarding adult-use cannabis production, distribution, and
retail.
The decision by the Government of Manitoba to allow for private retail
distribution of cannabis while ensuring that public safety and
health concerns are the focal points of its cannabis policies is a
strong and welcomed approach. As responsible existing cannabis
businesses, Delta 9 and Canopy Growth plan to work collaboratively
within the proposed Manitoba
framework to bring locally produced products as well as the best
variety from across the country to future cannabis consumers
throughout the province.
The Companies submitted a collaborative expression of interest
in July, 2017 outlining their proposed participation in the
Manitoba market including
production and distribution functions with both companies pursuing
privately owned and operated retail.
"As provinces continue to roll out distribution and retail
strategies we are starting to gain a clearer understanding of our
operational needs leading into next year," said Mark Zekulin, President, Canopy Growth.
"Manitoba has signalled an
openness to private retail operations, and as responsible private
companies already meeting the strict regulations for the production
and sale of medical cannabis across the country, we believe our
track record positions us well to satisfy the government's
objectives while meeting the needs of Manitoba consumers. We are proud to partner
with a respected, responsible local Manitoba company in Delta 9 to bring our
offering forward."
While working together in Manitoba, Delta 9 has also entered into a
distribution arrangement with Canopy Growth that will allow Delta 9
to expand its retail presence outside the province as Canopy
pursues distribution deals similar to the agreement it entered with
the Province of New Brunswick in
September, 2017, to bring the highest quality and best variety of
products to consumers across the country.
"As a cannabis producer headquartered in Winnipeg, our team is very pleased at the
prospect of expanding our operations to include physical locations
in addition to our existing e-commerce solution," said Delta 9
Co-Founder and CEO John
Arbuthnot,.
About Delta 9
Delta 9 Cannabis Inc., through its
wholly-owned subsidiary, Delta 9 Bio-tech, is a licensed producer
of medical marijuana pursuant to Health Canada's Access to Cannabis
for Medical Purposes Regulations (ACMPR). The company operates an
80,000 square foot, expandable, state-of-the-art production
facility in Winnipeg, Manitoba,
Canada.
The company's shares trade on the TSX-V under the stock symbol
'NINE'.
For more information please visit Delta9.ca.
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking
statements, which reflect the expectations of management regarding
the Company's future business plans. Forward-looking statements
consist of statements that are not purely historical, including any
statements regarding beliefs, plans, expectations or intentions
regarding the future. Forward looking statements in this news
release include statements relating Delta 9's future expansion
plans. Such statements are subject to risks and uncertainties that
may cause actual results, performance or developments to differ
materially from those contained in the statements, including that:
the Company's currently contemplated expansion and development
plans to cease or otherwise change. No assurance can be given that
any of the events anticipated by the forward-looking statements
will occur or, if they do occur, what benefits the Company will
obtain from them. Readers are urged to consider these factors
carefully in evaluating the forward-looking statements contained in
this news release and are cautioned not to place undue reliance on
such forward-looking statements, which are qualified in their
entirety by these cautionary statements. These forward-looking
statements are made as of the date hereof and the Company disclaims
any intent or obligation to update publicly any forward-looking
statements, whether as a result of new information, future events
or results or otherwise, except as required by applicable
securities laws.
SOURCE Delta 9 Cannabis Inc.